Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SGS Signs Analytical Testing Agreement with AstraZeneca | Contract Pharma
Breaking News, Collaborations & Alliances

SGS Signs Analytical Testing Agreement with AstraZeneca

Will provide safety, quality control and analytical testing services in support of a COVID-19 vaccine candidate AZD1222.

SGS has signed an agreement with AstraZeneca for the provision of safety, quality control and analytical testing services in support of AZD1222—a COVID-19 vaccine candidate co-invented by the University of Oxford and its spin-out company, Vaccitech and licensed by AstraZeneca.
 
SGS will conduct vaccine bulk harvest and drug substance testing from its Biosafety Center of Excellence in Glasgow, Scotland. The recently expanded laboratory provides testing of cell banks, vaccines, gene and cell therapies, monoclonal antibodies and other recombinant protein based biological medicines, including a vaccine testing solution suitable for coronavirus.
 
“As pioneers in the development of the biosafety testing industry, our team at Glasgow’s Biosafety Center of Excellence is proud to be part of this important development program,” said Archie Lovatt, scientific operations director, biosafety, SGS. “We welcome the opportunity to join forces with AstraZeneca to provide testing in support of the AZD1222 vaccine candidate.”
 
In addition to the viral bulk harvest testing, SGS will also conduct quality control and analytical testing of the vaccine production in its laboratory in Wavre, Belgium. This site, which is qualified as a center of excellence in GMP large molecule testing, will support batch release and stability testing.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters